# VIGABATRIN
> **ANDA211592** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2019-12-03
## Drug
- **FDA Application Number:** ANDA211592
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VIGABATRIN
- **Generic name:** VIGABATRIN
- **Active ingredients:** VIGABATRIN
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Cipla USA, Inc.
- **First approval:** 2019-12-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211592)
---
*MORVS · CC0 1.0*